The immunohistochemistry data revealed that there are very few CD8+ T cells in established MC38 tumors, suggesting that more favorable survival outcomes might be achieved in a tumor with more CD8+ TILs or upon administration of a different payload. Here, CD8A is linked to neoplasm.